Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Number of holders
-
183
-
Total 13F shares, excl. options
-
198,393,444
-
Shares change
-
+24,286,073
-
Total reported value, excl. options
-
$2,990,825,396
-
Value change
-
+$373,880,068
-
Put/Call ratio
-
1.13%
-
Number of buys
-
127
-
Number of sells
-
-50
-
Price
-
$15.08
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q3 2017
235 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock as of Q3 2017.
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) has 183 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 198,393,444 shares
of 308,713,740 outstanding shares and own 64.26% of the company stock.
Largest 10 shareholders include FMR LLC (19,315,817 shares), PERCEPTIVE ADVISORS LLC (17,888,597 shares), BlackRock Inc. (13,369,236 shares), VANGUARD GROUP INC (13,280,868 shares), Redmile Group, LLC (11,012,561 shares), JENNISON ASSOCIATES LLC (9,772,025 shares), STATE STREET CORP (8,151,091 shares), PRICE T ROWE ASSOCIATES INC /MD/ (8,092,031 shares), JANUS HENDERSON GROUP PLC (7,434,314 shares), and Palo Alto Investors, LLC (7,420,288 shares).
This table shows the top 183 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.